EXTREME PRICE VARIATION IN GENERIC BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER DRUGS

被引：0
|
作者：
Theisen, Katherine
Park, Seo Young
Jeong, Kwonho
Bandari, Jathin
Odisho, Anobel
Jacobs, Bruce
Davies, Benjamin
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP76-19
引用
收藏
页码：E1026 / E1026
页数：1
相关论文
共 50 条
  • [21] Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms
    Park, Yong Hyun
    Kim, Tae Hyo
    Lee, Seung Wook
    Chung, Byung Ha
    Cho, Jin Seon
    Lee, Ji Youl
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2017, 9 (02) : 75 - 81
  • [22] Bladder compliance in patients with benign prostatic hyperplasia
    Abrams, P
    [J]. NEUROUROLOGY AND URODYNAMICS, 1997, 16 (01) : 29 - 29
  • [23] Benign prostatic hyperplasia mimicking bladder tumor
    Hsu, TH
    Matin, SF
    [J]. UROLOGY, 2001, 57 (06) : 1166 - 1166
  • [24] THE INFLUENCE OF PROSTATIC URETHRAL ANESTHESIA IN OVERACTIVE DETRUSOR IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
    YOKOYAMA, O
    NAGANO, KI
    KAWAGUCHI, K
    UEKI, O
    OHKAWA, M
    [J]. JOURNAL OF UROLOGY, 1994, 151 (06): : 1554 - 1556
  • [25] URGENCY SEVERITY HAS IMPACT ON THE TREATMENT OUTCOMES IN THE MALE BENIGN PROSTATIC HYPERPLASIA WITH OVERACTIVE BLADDER PATIENTS
    Cho, S.
    Lee, K.
    Cho, I
    [J]. NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S446 - S447
  • [26] ASESSMENT OF THE EFFECTIVENESS OF THE COMBINED TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER WITH PHYTOTHERAPY AND ANTICHOLINERGIC DRUG
    Kanchev, S. K.
    Popov, V. P.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 598 - 598
  • [27] Clinical Efficacy of α 1-blocker Naftopidil in Patients with Overactive Bladder Associated with Benign Prostatic Hyperplasia
    Kakizaki, Hidehiro
    Tanaka, Hiroshi
    Mitsui, Takahiko
    Nonomura, Katsuya
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2009, 1 (01) : 35 - 39
  • [28] Efficacy of Alfuzosin with or without Tolterodine, in Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms
    Memon, Imran
    Javed, Atif
    Pirzada, Abdul Jabbar
    Abdullah, Aziz
    Ali, Sajid
    Ahmed, Syed Farhan
    [J]. RAWAL MEDICAL JOURNAL, 2014, 39 (04): : 421 - 424
  • [29] Emerging drugs for the treatment of benign prostatic hyperplasia
    Thomas, Dominique
    Chughtai, Bilal
    Kini, Mitali
    Te, Alexis
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 201 - 212
  • [30] Future drugs for the treatment of benign prostatic hyperplasia
    Karl-Erik Andersson
    C. R. Chapple
    K. Höfner
    [J]. World Journal of Urology, 2002, 19 : 436 - 442
12345